| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/20/2008 | CN101244265A Composition for improving stomach malaise symptom |
| 08/20/2008 | CN101244264A New purpose of antialcoholic drug containing acetaldehyde dehydrogenase |
| 08/20/2008 | CN101244263A Mixture containing mix interferon-alpha hypotype |
| 08/20/2008 | CN101244262A Medicament combination preparation for treating bacterial infection |
| 08/20/2008 | CN101244261A Biological agent containing non-renaturation recombinant protein, preparation method and application thereof |
| 08/20/2008 | CN101244260A Combined medicament for treating chronic hepatitis B |
| 08/20/2008 | CN101244259A Thymus gland peptide alpha1sustained-release microsphere preparation for injection and preparation thereof |
| 08/20/2008 | CN101244258A Use of TAT-N25 polypeptide in treating cell growth exception dermatosis such as psoriasis |
| 08/20/2008 | CN101244257A Application of type II collagen allosteric peptide for treating rheumatoid arthritis with nasal mucosa medicine administration |
| 08/20/2008 | CN101244256A Micro/sub-micro emulsion in situ gel rubber preparation of cyclosporins A for eyes and preparation thereof |
| 08/20/2008 | CN101244255A Thymus gland pentapeptide injection and uses thereof |
| 08/20/2008 | CN101244254A Noncovalent complexes formed with glutathione and amino acid |
| 08/20/2008 | CN101244114A Composition for improving and treating gastrointestinal tract indigestion symptom |
| 08/20/2008 | CN101244072A Application of asiaticoside in pulmonary fibrosis resistant delayed period |
| 08/20/2008 | CN101244043A Bivalirudin freeze-dried injection and preparation thereof |
| 08/20/2008 | CN101244035A Cyclosporins A emulsion preparations for eyes and preparation thereof |
| 08/20/2008 | CN100412196C Protection against environmental toxicity through manipulation of processing of messenger RNA precursors |
| 08/20/2008 | CN100412188C Biologically active native biomatrix composition |
| 08/20/2008 | CN100412091C Analogs of parathyroid hormone |
| 08/20/2008 | CN100412090C Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 08/20/2008 | CN100412087C Sequence number2 bioactive peptide |
| 08/20/2008 | CN100412086C Glycopeptide compositions |
| 08/20/2008 | CN100411684C Use of FVIIa or tissue factor antagonist for regulating gene expression and cell migration or chemotaxis |
| 08/20/2008 | CN100411683C Medicinal compositions containing ghrelin |
| 08/20/2008 | CN100411617C Use of flavone compounds in preparing medicament |
| 08/20/2008 | CN100411615C Effect of aminoguanidine for curing wound surface in refractory to treatment |
| 08/19/2008 | US7414169 Detecting modulator of preferential gene expression; obtain cell from human or nematode, incubate cells with modulator, monitor cells for decrease in preferential gene expresssion |
| 08/19/2008 | US7414139 Catalytic antioxidants and methods of use |
| 08/19/2008 | US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping |
| 08/19/2008 | US7414120 enhances ubiquitination of phosphorylated I kappa B; human E3 ubiquitin ligase polypeptides; inflammatory diseases, autoimmune diseases, cancer and viral infections |
| 08/19/2008 | US7414113 Increased ability to convert 5-fluorocytosine prodrug to its toxic form |
| 08/19/2008 | US7414110 Human calcium channel compositions and methods |
| 08/19/2008 | US7414109 FIAT nucleic acids and proteins and uses thereof |
| 08/19/2008 | US7414108 novel prostatic acid phosphatase and corresponding coding region derived from mouse; immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation. |
| 08/19/2008 | US7414107 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 08/19/2008 | US7414105 Peptide dimer bonded to polyethylene glycol through amide groups; insufficient or defective red blood cell production |
| 08/19/2008 | US7414035 hKIS composition and methods of use |
| 08/19/2008 | US7414034 Administering antibody polynucleotide; controlling glutamate receptors |
| 08/19/2008 | US7414033 Modulation of diacylglycerol acyltransferase 1 expression |
| 08/19/2008 | US7414029 Antagonistic peptides of prostaglandin E2 receptor subtype EP4 |
| 08/19/2008 | US7414028 Growth factor analogs |
| 08/19/2008 | US7414027 Peptide antagonists of vascular endothelial growth factor |
| 08/19/2008 | US7414026 Inhibitors of NF-kappaB activation |
| 08/19/2008 | US7414025 derived from a protein from the inner membrane of plant chloroplasts; for the importation of heterologous proteins into chloroplasts |
| 08/19/2008 | US7414024 B-cell differentiation factor (il-6); anticancer agents; antisense agents; monoclonal antibody |
| 08/19/2008 | US7414023 polypeptides/peptidomimetics; solid phase synthesis; for use in diagnositc assays |
| 08/19/2008 | US7414022 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 08/19/2008 | US7414021 Method and composition for restoration of age related tissue loss in the face or selected areas of the body |
| 08/19/2008 | US7414020 DNA expression vector; host cell transformed, transfected or infected with the vector; transgenic cell, tissue or organism; HCDS1 protein |
| 08/19/2008 | US7414019 Fibroblast growth factor; therapy for bone disorders |
| 08/19/2008 | US7413895 Nucleotide sequences coding cell surface protein associated with amino acid transport for use in identifying modlator for treatment and prevention of cell proliferative disorders; antitumor agents; antiproliferative agents |
| 08/19/2008 | US7413885 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis |
| 08/19/2008 | US7413884 Using antibodies as hydrolysis catalysts; reducing concentration of amyloid plaque |
| 08/19/2008 | US7413877 Bacterial expression of bowman-birk protease inhibitors and variants thereof |
| 08/19/2008 | US7413873 Method of detection and treatment of colon cancer |
| 08/19/2008 | US7413870 Combining a SAK polypeptide or fragment thereof with a Chk2 polypeptide and the compound, determining the binding of the SAK polypeptide or fragment thereof to Chk2 for identifying a compound capable of interfering with binding of a SAK |
| 08/19/2008 | US7413867 Contacting polynucleotide with acetylthiourea, N,N-dimethylthioformamide, N,N'-diphenylthiourea, N-ethylthiourea, 2-imidazolidinethione, 4(6)-methyl-2-thiouracil, N-methylthiourea, phenylthio-carbamid, 6-phenyl-2-thiouracil, 6-propyl-2-thiouracil, tetramethylthiourea, thioacetamide, thioacetanilide |
| 08/19/2008 | US7413864 Treating cancer using a telomerase vaccine |
| 08/19/2008 | US7413863 Identification of substances that inhibit NEMO oligomerization |
| 08/19/2008 | US7413860 Testing for disease by analyzing if gene has mutation |
| 08/19/2008 | US7413853 Modulation of metabolism of steroids and xenobiotics |
| 08/19/2008 | US7413781 Gels for encapsulation of biological materials |
| 08/19/2008 | US7413753 Containing an effective amount of an effervescent agent. |
| 08/19/2008 | US7413743 Active immunization using a siderophore receptor protein |
| 08/19/2008 | US7413742 Clostridial toxin derivatives and methods for treating pain |
| 08/19/2008 | US7413739 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 08/19/2008 | US7413738 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |
| 08/19/2008 | US7413735 Pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis |
| 08/19/2008 | US7413031 Apparatus and method for maintaining control of a drilling machine |
| 08/19/2008 | US7412978 Augmentation and repair of vocal cord tissue defects |
| 08/19/2008 | CA2351618C Protein amsh and cdna thereof |
| 08/19/2008 | CA2330972C Fully recombinant tissue sealant compositions |
| 08/19/2008 | CA2120731C Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 08/16/2008 | CA2579119A1 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 08/15/2008 | CA2578647A1 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 08/14/2008 | WO2008098216A2 Compositions and methods to prevent cancer with cupredoxins |
| 08/14/2008 | WO2008098212A2 Extended release formulations of glucagon and other peptides and proteins |
| 08/14/2008 | WO2008098182A1 Methods and compositions related to inhibition of viral entry |
| 08/14/2008 | WO2008098169A2 Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone |
| 08/14/2008 | WO2008097812A1 Toxoplasma gondii oocyst protein |
| 08/14/2008 | WO2008097563A1 Methods for maintaining blood-brain barrier integrity in hypertensive subjects using a delta-pkc inhibitor |
| 08/14/2008 | WO2008097536A2 Compositions and methods for treating psychiatric diseases and disorders |
| 08/14/2008 | WO2008097503A2 Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation |
| 08/14/2008 | WO2008097497A2 Vegf pathway blockade |
| 08/14/2008 | WO2008096904A1 Mannose 6-phosphate-polyethylene glycol conjugate |
| 08/14/2008 | WO2008096865A1 Therapeutic agent for disease induced by dysfunction or degeneration of organ |
| 08/14/2008 | WO2008096826A1 Prophylactic agent for autoimmune disease |
| 08/14/2008 | WO2008096816A1 Angiogenesis inducer and polypeptide for use in the angiogenesis inducer |
| 08/14/2008 | WO2008096814A1 Novel polypeptide and antibacterial agent comprising the same as active ingredient |
| 08/14/2008 | WO2008096781A1 Betacellulin mutein |
| 08/14/2008 | WO2008096359A2 Agents for the treatment of multiple sclerosis and methods of using same |
| 08/14/2008 | WO2008096268A2 Autologous lymph node transfer in combination with vegf-c or vegf-d growth factor therapy to treat secondary lymphedema and to improve reconstructive surgery |
| 08/14/2008 | WO2008095735A1 Use of sirt7 for treating age-related diseases |
| 08/14/2008 | WO2008095652A1 Transport of drugs via the blood-brain barrier by means of apolipoproteins |
| 08/14/2008 | WO2008095357A1 Treatment for spinal muscular atrophy |
| 08/14/2008 | WO2008095276A1 Novel non-toxic composition and method of using such for treating a degenerative or an immune system-related disease |
| 08/14/2008 | WO2008077077A3 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors |
| 08/14/2008 | WO2008075333A3 Edible compositions for preventing hair loss |
| 08/14/2008 | WO2008071755A3 Casein-derived peptides having anxiolytic activity |
| 08/14/2008 | WO2008065543A3 Modified soluble fgf receptor fc fusions with improved biological activity |